Product
Supplier
Encyclopedia
Inquiry
Home > Specialty Chemicals > Elamipretide for Sale > SS31 - Peptides for Skin Care
SS31 - Peptides for Skin Care buy - large image1
SS31 - Peptides for Skin Care buy - image1
SS31 - Peptides for Skin Care buy - image2
SS31 - Peptides for Skin Care buy - image3
SS31 - Peptides for Skin Care buy - image4
SS31 - Peptides for Skin Care buy - image5
SS31 - Peptides for Skin Care buy - image6

SS31 - Peptides for Skin Care

105 Inquiries

Unit Price: Get Latest Price
CAS No.:

736992-21-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

rxc

Packaging:

20mg,30mg,10vials in one box or as your requirement

Price valid (until):

2026-09-05

This product has been removed from the shop temporarily..
Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
15 days
Qualification:
Main Products:

peptide

  • Product Details

  • Seller Information

  • History Price

  • Inquiry History

  • Description


      ProShop SS31 - Peptide product for anti-aging-Detailed Image 1duct Detail  


    Pls input...

    Items Specifications
    ss31 - Appearance: White powder
    ?
    - Solubility: Soluble in water and DMSO
    ?
    - Storage: -20℃, sealed and dry
    Common Specifications for Foreign Trade (Packaging)
    1mg, 5mg, 10mg, 50mg, 100mg, 1g, 5g, 10g

    II. Bottle Capacity (Main Specification)
    - Research/ Raw material grade: 1mg, 5mg, 10mg, 15mg, 20mg, 30mg, 100mg, 1000mg ?
    Clinical/Export Trade Commonly Used: 5mg/bottle, 10mg/bottle, 15mg/bottle, 20mg/bottle, 30mg/bottle ?
    Clinical target dose: 4mg, 9mg, 12mg. Storage: -20 degrees, protected from light, sealed. After reconstitution, store at 2-8 degrees Celsius for 7 days before use.


    ECHEMI Editorial Reference
    Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
    Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Elamipretide Synthetic is a single, non-glycosylated polypeptide chain containing 4 amino acids, having a molecular mass of 640 Dalton and a Molecular formula of C32H49N9O5 .

    Basic Info
    Product Name:

    Elamipretide

    Other Name:

    D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31;ELAMIPRETIDE, >99%

    CAS No.:

    736992-21-5

    Molecular Formula:

    C32H49N9O5

    InChIKeys:

    SFVLTCAESLKEHH-WKAQUBQDSA-N

    Molecular Weight:

    639.79

    Exact Mass:

    639.38566570

    EC Number:

    205-858-1

    UNII:

    87GWG91S09

    DSSTox ID:

    DTXSID50471988

    Color/Form:

    White to Off-White

    Categories:

    Characteristics
    Density:

    1.34±0.1 g/cm3(Predicted)

    PKA:

    10.10±0.25(Predicted)

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    peptide

    Location:

    south road and north road

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    15 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2022

    Hebei runxuchen trading Co., Ltd. is a modern and advanced enterprise specializing in the production and export of  peptide products, synthetic peptides, cosmetic raw materials, beauty and slimming products etc Products are widely used in health products, peptides and other fields. Our plant covers an area of 1000 m². The proposed workshop will be built according to GMP standards. We provide our customers with quality products and first-class service. Now, we can provide G-KG service to our customers.

    • High-Quality Peptides: Our company specializes in premium-grade peptides, ensuring the highest standards of purity and efficacy. Each product undergoes rigorous testing to guarantee superior quality and performance.

    • Cutting-Edge Technology: We leverage the latest advancements in peptide synthesis and production technology. Our state-of-the-art facilities and innovative processes enable us to deliver peptides with exceptional precision and consistency.

    • Custom Solutions: We offer tailored peptide solutions to meet the specific needs of our clients. Whether you require bespoke formulations or custom quantities, our experienced team is dedicated to providing personalized support and solutions.

    • Extensive Expertise: With years of experience in the peptide industry, our team of experts is well-versed in the complexities of peptide development and applications. We are committed to providing insightful guidance and technical support to help you achieve your goals.

    • Comprehensive Product Range: Our diverse portfolio of peptide products covers a wide range of applications, including research, pharmaceutical development, and cosmetic formulations. This allows us to cater to various industries and meet different customer needs.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    105 Inquiries
    Country Product Purchase Quantity Date Posted
    Germany

    SS31

    1000 MG Oct 23, 2026
    United States

    SS-31

    10 MG Oct 16, 2026
    Canada

    Ss31

    20 MG Oct 16, 2026
    United States

    SS31

    1 G Oct 15, 2026
    Australia

    Ss-31

    50 MG Sep 28, 2026
    United States

    SS31

    30 MG Sep 20, 2026
    Australia

    Ss-31 (Elamipretide)

    1000 PCS Sep 16, 2026
    Philippines

    SS-31

    30 MG Sep 15, 2026
    United States

    SS-31

    50 MG Sep 8, 2026
    United States

    SS31

    10 MG Aug 28, 2026
    United States

    SS-31

    20 MG Aug 25, 2026
    United States

    SS31

    20 MG Aug 25, 2026
    Australia

    SS-31

    30 MG Aug 24, 2026
    United States

    Ss-31 Elamipretide

    1 PCS Aug 16, 2026
    Malaysia

    ss31

    20 MG Aug 12, 2026
    Canada

    Ss31

    1 G Jul 24, 2026
    Brazil

    SS-31 Lyophilized Powder

    0.1 G Jul 9, 2026
    Turkey

    SS-31 (Elamipretide MTP-131) CAS 99% White Powder

    100 G Jun 28, 2026
    India

    Elamipretide

    1 G Jun 23, 2026
    France

    Elamipretide

    3 G Jun 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.